Inventor · disambiguated record
Gregory J. Larosa
Also filed as: LAROSA GREGORY J
23 granted patents·11 pending applications·622 citations·filing 1994–2016
97Inventor score
Files withMILLENNIUM PHARM INC25BIKAM PHARMACEUTICALS INC3LAROSA GREGORY J2REPLIGEN CORP2GARVEY DAVID S1
Top patents by PatentIndex Score
34 records- 0198US6696550B2Humanized anti-CCR2 antibodies and methods of use thereforMILLENNIUM PHARM INC·Filed 2001·Granted Feb 24, 2004·135 cites·74 claims
- 0297US6727349B1Recombinant anti-CCR2 antibodies and methods of use thereforMILLENNIUM PHARM INC·Filed 2000·Granted Apr 27, 2004·81 cites·62 claims
- 0397US6406694B1Anti-CCR2 antibodiesMILLENNIUM PHARM INC·Filed 2001·Granted Jun 18, 2002·73 cites·4 claims
- 0495US6491915B2Anti-CCR2 antibodies and methods of use thereforMILLENNIUM PHARM INC·Filed 2001·Granted Dec 10, 2002·39 cites·4 claims
- 0594US6406865B2Method of inhibiting interaction of cells bearing CCR2 by Anti-CCR2 amino-terminal domain antibodiesMILLENNIUM PHARM INC·Filed 2001·Granted Jun 18, 2002·34 cites·18 claims
- 0692US6448021B1Method of inhibiting cell function associated with CCR2 by anti-CCR2 amino-terminal domain antibodiesMILLENNIUM PHARM INC·Filed 2001·Granted Sep 10, 2002·24 cites·21 claims
- 0792US6395497B1Method of inhibiting leukocyte trafficking by anti-CCR2 amino-terminal domain antibodiesMILLENNIUM PHARM INC·Filed 2001·Granted May 28, 2002·25 cites·16 claims
- 0891US6312689B1Anti-CCR2 antibodies and methods of use thereforMILLENNIUM PHARM INC·Filed 1998·Granted Nov 6, 2001·48 cites·43 claims
- 0990US7442775B2Humanized anti-CCR2 antibodies and methods of use thereforMILLENNIUM PHARM INC·Filed 2004·Granted Oct 28, 2008·15 cites·38 claims
- 1090US6458353B1Anti-CCR2 antibodies and methods of use thereforMILLENNIUM PHARM INC·Filed 2001·Granted Oct 1, 2002·19 cites·42 claims
- 1190US6451522B2Anti-CCR2 antibodies and methods of use thereforMILLENNIUM PHARMACUETICALS INC·Filed 2001·Granted Sep 17, 2002·27 cites·24 claims
- 1289US7566450B2Humanized anti-CCR2 antibodies and methods of use thereforMILLENNIUM PHARM INC·Filed 2007·Granted Jul 28, 2009·6 cites·18 claims
- 1387US7473421B2Humanized anti-CCR2 antibodies and methods of use thereforMILLENNIUM PHARM INC·Filed 2004·Granted Jan 6, 2009·11 cites·23 claims
- 1486US6469002B1Imidazolidine compoundsMILLENNIUM PHARM INC·Filed 2001·Granted Oct 22, 2002·23 cites·22 claims
- 1585US8227211B2Humanized anti-CCR2 antibodies and methods of use thereforLAROSA GREGORY J·Filed 2008·Granted Jul 24, 2012·5 cites·23 claims
- 1684US7566539B2Anti-CCR2 antibodies and methods of use thereforMILLENNIUM PHARM INC·Filed 2003·Granted Jul 28, 2009·9 cites·18 claims
- 1782US6352832B1Anti-CCR2 antibodies and methods of use thereforMILLENNIUM PHARM INC·Filed 1999·Granted Mar 5, 2002·24 cites·72 claims
- 1875US8926971B2Humanized anti-CCR2 antibodies and methods of use thereforLAROSA GREGORY J·Filed 2012·Granted Jan 6, 2015·1 cites·23 claims
- 1973US9562022B2Opsin-binding ligands, compositions and methods of useGARVEY DAVID S·Filed 2010·Granted Feb 7, 2017·3 cites·14 claims
- 2069US2015086546A1Humanized anti-ccr2 antibodies and methods of use thereforMILLENNIUM PHARM INC·Filed 2014·Application pending·0 cites
- 2167US2008268536A1Humanized Anti-CCR2 Antibodies and Methods of Use ThereforMILLENNIUM PHARM INC·Filed 2007·Application pending·0 cites
- 2267US2008241923A1Humanized Anti-CCR2 Antibodies and Methods of Use ThereforMILLENNIUM PHARM INC·Filed 2007·Application pending·0 cites
- 2366US9499464B2Opsin-binding ligands, compositions and methods of useBIKAM PHARMACEUTICALS INC·Filed 2012·Granted Nov 22, 2016·1 cites·16 claims
- 2462US2009169541A1Humanized Anti-CCR2 Antibodies and Methods of Use ThereforMILLENNIUM PHARM INC·Filed 2007·Application pending·0 cites
- 2561US2004265303A1Anti-CCR2 antibodies and methods of use thereforMILLENNIUM PHARM INC·Filed 2004·Application pending·0 cites
- 2660US5789539AChemokine-like proteins and methods of useREPLIGEN CORP·Filed 1995·Granted Aug 4, 1998·11 cites·19 claims
- 2755US6495569B1Imidazolidine compoundsMILLENNIUM PHARM INC·Filed 2001·Granted Dec 17, 2002·1 cites·21 claims
- 2855US2003165494A1Anti-CCR2 antibodies and methods of use thereforMILLENNIUM PHARM INC·Filed 2001·Application pending·0 cites
- 2953US2004127507A1Imidazolidine compoundsMILLENNIUM PHARM INC·Filed 2003·Application pending·0 cites
- 3051US2004122026A1Imidazolidine compoundsMILLENNIUM PHARM INC·Filed 2003·Application pending·0 cites
- 3149US2003225288A1Imidazolidine compoundsMILLENNIUM PHARM INC·Filed 2002·Application pending·0 cites
- 3242US2017137398A1Opsin-binding ligands, compositions and methods of useBIKAM PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 3341US5656724AChemokine-like proteins and methods of useREPLIGEN CORP·Filed 1994·Granted Aug 12, 1997·7 cites·6 claims
- 3441US2017037018A1Opsin-Binding Ligands, Compositions and Methods of UseBIKAM PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Gregory J. Larosa files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →